These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 12808304

  • 1. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin.
    Iwamoto T, Kagawa Y, Kojima M.
    Biol Pharm Bull; 2003 Jun; 26(6):876-9. PubMed ID: 12808304
    [Abstract] [Full Text] [Related]

  • 2. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus].
    Shirai M, Ide K, Sato M, Murakami M, Tanaka Y, Sato A, Chida K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Recent findings based on the results of the post-marketing surveillance of vancomycin hydrochloride for intravenous infusion].
    Shimada K.
    Jpn J Antibiot; 2003 Aug; 56(4):259-71. PubMed ID: 14567250
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
    Takahashi Y, Takesue Y, Takubo S, Ishihara M, Nakajima K, Tsuchida T, Ikeuchi H, Uchino M.
    J Infect Chemother; 2013 Aug; 19(4):709-16. PubMed ID: 23345049
    [Abstract] [Full Text] [Related]

  • 8. Pediatric vancomycin dosing: Trends over time and the impact of therapeutic drug monitoring.
    Balch AH, Constance JE, Thorell EA, Stockmann C, Korgenski EK, Campbell SC, Spigarelli MG, Sherwin CM.
    J Clin Pharmacol; 2015 Feb; 55(2):212-20. PubMed ID: 25264036
    [Abstract] [Full Text] [Related]

  • 9. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection.
    Hirose K, Marui A, Arai Y, Nomura T, Inoue S, Kaneda K, Kamitani T, Fujita M, Mitsuyama M, Tabata Y, Komeda M.
    J Vasc Surg; 2006 Aug; 44(2):377-82. PubMed ID: 16890872
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetics of vancomycin in Japanese adult patients.
    Yasuhara M, Iga T, Zenda H, Okumura K, Oguma T, Yano Y, Hori R.
    Ther Drug Monit; 1998 Apr; 20(2):139-48. PubMed ID: 9558127
    [Abstract] [Full Text] [Related]

  • 11. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.
    Moise PA, Sakoulas G, Forrest A, Schentag JJ.
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2582-6. PubMed ID: 17452488
    [Abstract] [Full Text] [Related]

  • 12. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Mogle BT, Steele JM, Seabury RW, Dang UJ, Kufel WD.
    Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
    [Abstract] [Full Text] [Related]

  • 13. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
    Fukuoka T, Domon H, Kakuta M, Ishii C, Hirasawa A, Utsui Y, Ohya S, Yasuda H.
    Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
    [Abstract] [Full Text] [Related]

  • 14. In vivo serum concentration of vancomycin in antibiotic-loaded acrylic cement for the treatment and prevention of periprosthetic hip infection.
    Oe K, Iida H, Ueda N, Nakamura T, Okamoto N, Ueda Y.
    J Orthop Sci; 2017 Jul; 22(4):710-714. PubMed ID: 28342695
    [Abstract] [Full Text] [Related]

  • 15. Vancomycin dosing and monitoring.
    Med Lett Drugs Ther; 2009 Apr 06; 51(1309):25. PubMed ID: 19343006
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
    Yamaguchi Y, Hanaki H, Yanagisawa C, Ikeda-Dantsuji Y, Hashimoto T, Yazaki H, Sugahara K, Yanagisawa T, Kawajiri H, Sato S, Ishizaki A, Tachihara-Sato R, Takahashi Y, Ono T, Kageyama Y, Kawaguchi T, Tamura A, Hagane K, Sunakawa K.
    J Infect Chemother; 2009 Oct 06; 15(5):274-8. PubMed ID: 19856063
    [Abstract] [Full Text] [Related]

  • 17. [Effect of pharmacists' intervention on the antibiotic therapy for the methicillin-resistant Staphylococcus aureus (MRSA) infectious diseases in the intensive care unit].
    Imaura M, Kohata Y, Kobayashi K, Takahashi H, Yokoyama H, Akase T, Yamada Y.
    Yakugaku Zasshi; 2011 Apr 06; 131(4):563-70. PubMed ID: 21467796
    [Abstract] [Full Text] [Related]

  • 18. [Therapeutic monitoring of vancomycin in routine clinical practice].
    Kacířová I, Grundmann M.
    Vnitr Lek; 2014 Oct 06; 60(10):846-51. PubMed ID: 25382007
    [Abstract] [Full Text] [Related]

  • 19. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
    Kitzis MD, Goldstein FW.
    Clin Microbiol Infect; 2006 Jan 06; 12(1):92-5. PubMed ID: 16460555
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
    Hirai T, Hanada K, Kanno A, Akashi M, Itoh T.
    Eur J Clin Pharmacol; 2019 Jun 06; 75(6):859-866. PubMed ID: 30770940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.